EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Leveraging MRI to reduce overtreatment in low‑grade prostate cancer: a retrospective single‑centre cohort study

Katarzyna Skrobisz iD, Kevin Miszewski, Bartłomiej Marczak, Laura Miszewska, Jakub Kulski iD, Marcin Matuszewski

Therapeutic Advances in Urology · 2026-08 · 18

DOI: 10.1177/17562872261463095 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Therapeutic Advances in Urology, online erschienen am 04.08.2026. Verfasst von Katarzyna Skrobisz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Medical University of Gdansk, Smoluchowskiego 17, Gdańsk 80-2014, Poland. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer is one of the most common malignancies in men worldwide. Radical prostatectomy is an effective curative treatment, but a noticeable number of men are ultimately found to have clinically insignificant disease, such as a Gleason score of 3 plus 3, on final histopathology. This suggests that some patients may undergo unnecessary surgery. The widespread adoption of multiparametric MRI has improved tumour detection and targeted biopsy accuracy, yet its potential role in preventing overtreatment is not fully understood. Because some low-risk tumours demonstrate low conspicuity on MRI, we hypothesised that specific MRI features, particularly low lesion conspicuity and PI-RADS 3 or lower, may be associated with final Grade Group 1 pathology in men undergoing radical prostatectomy.

Objectives

The purpose of this study was to assess whether pre-operative multiparametric MRI can help identify men with potentially indolent prostate cancer and reduce unnecessary radical prostatectomies. We focused on MRI features such as PI-RADS 3 or lower, low lesion conspicuity and overall imaging quality to see how strongly they relate to final Grade Group 1 in men who were selected for surgery.

Design

Retrospective single-centre cohort study.

Methods

We reviewed 400 consecutive men who underwent robot-assisted radical prostatectomy for presumed clinically significant prostate cancer. Final pathology identified 13 men with Grade Group 1 disease. Pre-operative mpMRI examinations were reassessed for PI-RADS category, lesion location, lesion conspicuity and overall image quality to determine whether imaging features were associated with low-risk pathology.

Results

Analyses showed that certain MRI characteristics were frequently associated with Gleason 3 plus 3 pathology. Several patients who proceeded to surgery had inconspicuous, equivocal or low probability MRI lesions such as PI-RADS 2 or 3 that lacked features typically associated with clinically significant cancer. Recognising these signatures may refine patient selection and support broader use of active surveillance.

Conclusion

Assessment of MRI appearance, lesion conspicuity and PI-RADS category may improve selection for surgery and reduce overtreatment. MRI-based identification of low-grade prostate cancer could help avoid unnecessary prostatectomies and the associated morbidity while preserving oncologic safety.

Schlagwörter

Stichwörter der Autor:innen

Gleason 3 + 3PI-RADSPSAPSAdlow-grade tumoursmpMRIprostate cancer

Autor:innen und Institutionen

  • Department of Radiology, Medical University of Gdansk, Smoluchowskiego 17, Gdańsk 80-2014, Poland.
  • Department of Urology, Medical University of Gdańsk, Gdańsk, Poland.
  • Medical University of Gdańsk, Gdańsk, Poland.

ORCID-Profile: Katarzyna Skrobisz, Jakub Kulski

Zitieren

APA

Skrobisz, K., Miszewski, K., Marczak, B., Miszewska, L., Kulski, J., & Matuszewski, M. (2026). Leveraging MRI to reduce overtreatment in low‑grade prostate cancer: a retrospective single‑centre cohort study. Therapeutic Advances in Urology, 18. https://doi.org/10.1177/17562872261463095

Vancouver

Skrobisz K, Miszewski K, Marczak B, Miszewska L, Kulski J, Matuszewski M. Leveraging MRI to reduce overtreatment in low‑grade prostate cancer: a retrospective single‑centre cohort study. Therapeutic Advances in Urology. 2026;18. doi:10.1177/17562872261463095

BibTeX
@article{Skrobisz2026,
  author = {Skrobisz, Katarzyna and Miszewski, Kevin and Marczak, Bartłomiej and Miszewska, Laura and Kulski, Jakub and Matuszewski, Marcin},
  title = {Leveraging MRI to reduce overtreatment in low‑grade prostate cancer: a retrospective single‑centre cohort study},
  journal = {Therapeutic Advances in Urology},
  year = {2026},
  volume = {18},
  doi = {10.1177/17562872261463095}
}
Kostenlos starten →